Minoryx focuses its research on orphan CNS diseases, a large group of rare diseases affecting the central nervous system
view more >
A rare inherited peroxisomal neurodegenerative disorder, chronically debilitating and life-threatening.
MIN-102 is Minoryx’s candidate for X-linked Adrenoleukodystrophy. It has successfully completed phase 1 clinical trials and is now in phase 2/3.